Partisanship, Funding And Privacy Concerns Could Obstruct PrEP Access by Luke Zarzecki, Inside Health Policy | Sep 18, 2023
Hep C is treatable, but still claiming lives. Can Biden’s 5-year plan eliminate it? by Michelle Andrews, CBS News | Sep 15, 2023
After backlash, Blue Cross NC lowers out-of-pocket costs on HIV treatments by Brian Gordon, The News & Observer | Sep 14, 2023
LGBTQ Agenda: North Carolina insurer lowers copay for HIV drugs after discrimination complaint by John Ferrannini, Bay Area Reporter | Sep 12, 2023
